ArticleActa diabetologica2024

Health and economic impact of dapagliflozin for type 2 diabetes patients who had or were at risk for atherosclerotic cardiovascular disease in the Italian general practitioners setting: a budget impact analysis.

Paolo Angelo Cortesi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.